Volume Anomaly Alert

Volume Anomaly Alert
Spar Group Inc. (NASDAQ: SGRP) SPAR Group, Inc. is a diversified international merchandising and marketing services Company and provides a broad array of services worldwide to help companies improve their sales, operating efficiency and profits at retail locations. The Company provides merchandising and other marketing services to manufacturers, distributors and retailers worldwide, primarily in mass merchandiser, office supply, value, grocery,... Read More

5 Stocks Surging Worth Watching

5 Stocks Surging Worth Watching
  LEDS SemiLEDs is a manufacturer of ultra-high brightness LED chips with state of the art fabrication facilities in Hsinchu Science Park, Taiwan. SemiLEDs specializes in the development and manufacturing of metal alloy vertical LED chips in blue (white), green and UV using our patented and proprietary MvpLED™ technology. This unique design allows for higher performance and longer lumen maintenance.... Read More

Fibrocell on the Rebound

Fibrocell on the Rebound
In a sea of red in the market place today following the UK’s decision to leave the European Union so aptly named Brexit, one stock managed to find its way to greener pastures. Fibrocell Science Inc. (NASDAQ: FCSC) was up 33% by market close, recovering from a 36% drop in its share price on June 8th after the Company revealed... Read More

Lpath Awarded $1.45 Million Grant

Lpath Awarded $1.45 Million Grant
Lpath, Inc. (NASDAQ: LPTN) share price surged over 43% to $0.91 on nearly 10 Million shares traded after announcing the Company has been awarded a $1.45 million two-year grant by the Defense Medical Research and Development Program (DMRDP), an agency of the U.S. Department of Defense (DoD). Lpath has developed three drug candidates, has advanced all three into clinical trials,... Read More

Aegerion and QLT Agree to Strategic Merger

Aegerion and QLT Agree to Strategic Merger
Aegerion_Pharmaceuticals, Inc. (NASDAQ:AEGR) and QLT Inc. (NASDAQ:QLTI) both received a well needed bump in the share price, although Aegerion benefited most with a 28% pop while closing at $1.71, up $0.38 with nearly 13 Million shares traded. The two companies entered into a definitive merger agreement under which Aegerion will be merged with a wholly owned indirect subsidiary of QLT,... Read More

Dehaier Medical Receives US$20 Million Investment

Dehaier Medical Receives US$20 Million Investment
Dehaier Medical Systems Ltd. (NASDAQ: DHRM) receives US$20 million to expand their wearable medical device business and to launch other new smart wearable devices and mobile medical solutions over the next few years. The Company entered into a definitive securities purchase agreement with Hangzhou Liaison Interactive Information Technology Co. Ltd., a publicly listed company on the Shenzhen Stock Exchange (Symbol:... Read More

Aytu BioScience Enters $2 Billion Testosterone Replacement Market

Aytu BioScience Enters $2 Billion Testosterone Replacement Market
Aytu_BioScience, Inc. (OTCQX: AYTU) is paying $2 million upfront and purchasing $2 million of Acerus Pharmaceuticals Corporation (TSX: ASP) common stock for an exclusive license agreement for the U.S. commercial rights to Natesto® Nasal Gel. Natesto is the first and only nasal formulation of testosterone approved by the U.S. Food and Drug Administration (FDA) as a replacement therapy for men... Read More

Arch Therapeutics, Inc. Breaking 52 Week High

Arch Therapeutics, Inc. Breaking 52 Week High
Arch Therapeutics, Inc. (OTCQB: ARTH), developer of the AC5 Surgical Hemostatic Device, has garnered some interest by retail investors as the stock broke through its 52 week high of $0.45 with above average volume. Arch announced last month they obtained favorable results from a broad panel of preclinical biocompatibility tests that were performed on AC5, which is required prior to... Read More